Brief: X4 Pharmaceuticals Reports Fourth-Quarter And Full-Year 2022 Financial Results

X4 Pharmaceuticals

21/03/2023 10:10

March 21 (Reuters) - X4 Pharmaceuticals Inc  XFOR.O :
    * X4 PHARMACEUTICALS REPORTS FOURTH-QUARTER AND FULL-YEAR
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
    * HAD $123.0 MILLION IN CASH, CASH EQUIVALENTS, RESTRICTED
CASH AS
OF DECEMBER 31, 2022
    * HAS SUFFICIENT FUNDS TO SUPPORT COMPANY OPERATIONS INTO Q2
OF
2024
    * REPORTED NET LOSS OF $29.1 MILLION FOR Q4
    * QTRLY LOSS PER SHARE $0.29
    * Q4 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7G5p3t 
Further company coverage:  XFOR.O 

 ((Reuters.Briefs@thomsonreuters.com;))